HRP20030838A2 - Aromatase inhibition to enhance assisted reproduction - Google Patents

Aromatase inhibition to enhance assisted reproduction

Info

Publication number
HRP20030838A2
HRP20030838A2 HR20030838A HRP20030838A HRP20030838A2 HR P20030838 A2 HRP20030838 A2 HR P20030838A2 HR 20030838 A HR20030838 A HR 20030838A HR P20030838 A HRP20030838 A HR P20030838A HR P20030838 A2 HRP20030838 A2 HR P20030838A2
Authority
HR
Croatia
Prior art keywords
enhance
assisted reproduction
aromatase inhibition
aromatase
inhibition
Prior art date
Application number
HR20030838A
Other languages
English (en)
Inventor
Robert
Mohamed
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of HRP20030838A2 publication Critical patent/HRP20030838A2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20030838A 2001-04-17 2002-04-17 Aromatase inhibition to enhance assisted reproduction HRP20030838A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28417801P 2001-04-17 2001-04-17
PCT/CA2002/000522 WO2002083240A1 (en) 2001-04-17 2002-04-17 Aromatase inhibition to enhance assisted reproduction

Publications (1)

Publication Number Publication Date
HRP20030838A2 true HRP20030838A2 (en) 2005-08-31

Family

ID=23089175

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030838A HRP20030838A2 (en) 2001-04-17 2002-04-17 Aromatase inhibition to enhance assisted reproduction

Country Status (32)

Country Link
US (1) US7846957B2 (cs)
EP (1) EP1381431B1 (cs)
JP (1) JP2004526764A (cs)
KR (1) KR20040012751A (cs)
CN (1) CN100377710C (cs)
AR (1) AR034310A1 (cs)
AT (1) ATE363906T1 (cs)
AU (1) AU2002249041B2 (cs)
BG (1) BG108316A (cs)
BR (1) BR0208968A (cs)
CA (1) CA2444932A1 (cs)
CY (1) CY1108021T1 (cs)
CZ (1) CZ299735B6 (cs)
DE (1) DE60220516T2 (cs)
DK (1) DK1381431T3 (cs)
EA (1) EA010354B1 (cs)
EE (1) EE200300512A (cs)
ES (1) ES2283541T3 (cs)
HR (1) HRP20030838A2 (cs)
HU (1) HUP0303795A2 (cs)
IL (2) IL158395A0 (cs)
MX (1) MXPA03009446A (cs)
NO (1) NO20034245L (cs)
NZ (1) NZ528501A (cs)
PL (1) PL366554A1 (cs)
PT (1) PT1381431E (cs)
SI (1) SI1381431T1 (cs)
SK (1) SK14252003A3 (cs)
UA (1) UA79591C2 (cs)
WO (1) WO2002083240A1 (cs)
YU (1) YU81303A (cs)
ZA (1) ZA200307514B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004004634A2 (en) * 2002-07-02 2004-01-15 Pharmacia & Upjohn Company Llc Infertility treatment with exemestane
CA2837494C (en) 2010-05-20 2019-12-31 University Of Saskatchewan Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
IN2014DN01619A (cs) * 2011-09-08 2015-05-15 Novartis Ag
BR112015026298A8 (pt) 2013-04-19 2019-12-24 Univ Saskatchewan veículo de dispensação para a dispensação de um inibidor da aromatase
CN107648594A (zh) * 2017-11-08 2018-02-02 广州市桐晖药业有限公司 枸橼酸氯米芬胶囊及其制备方法
CN118286143B (zh) * 2024-03-20 2025-07-18 郑州大学第三附属医院(河南省妇幼保健院) 注射用尿促卵泡素联合来曲唑在制备不孕症的试剂盒中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4845227A (en) * 1984-06-18 1989-07-04 Eli Lilly And Company Aromatase inhibitors from azoles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
DE4330237C2 (de) 1993-09-02 1995-11-30 Schering Ag 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0907351B2 (de) 1996-03-29 2012-04-18 Keyvest GmbH Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
WO1997040846A1 (en) 1996-04-30 1997-11-06 Takeda Chemical Industries, Ltd. COMBINED USE OF GnRH AGONIST AND ANTAGONIST
DE19622457A1 (de) 1996-05-24 1997-11-27 Schering Ag 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
ES2247710T3 (es) * 1997-06-20 2006-03-01 Akzo Nobel N.V. Antagonista de gonadotropina.
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation

Also Published As

Publication number Publication date
EP1381431A1 (en) 2004-01-21
HK1067987A1 (zh) 2005-04-22
DK1381431T3 (da) 2007-10-08
EP1381431B1 (en) 2007-06-06
US20040204393A1 (en) 2004-10-14
BR0208968A (pt) 2004-04-27
SK14252003A3 (sk) 2004-03-02
DE60220516D1 (de) 2007-07-19
IL158395A (en) 2009-06-15
SI1381431T1 (sl) 2007-08-31
ES2283541T3 (es) 2007-11-01
ATE363906T1 (de) 2007-06-15
NO20034245L (no) 2003-12-15
WO2002083240A9 (en) 2004-05-06
KR20040012751A (ko) 2004-02-11
JP2004526764A (ja) 2004-09-02
EA010354B1 (ru) 2008-08-29
AR034310A1 (es) 2004-02-18
MXPA03009446A (es) 2004-05-24
CN1549734A (zh) 2004-11-24
US7846957B2 (en) 2010-12-07
CZ20033108A3 (en) 2004-06-16
CY1108021T1 (el) 2013-09-04
CN100377710C (zh) 2008-04-02
CZ299735B6 (cs) 2008-11-05
CA2444932A1 (en) 2002-10-24
NO20034245D0 (no) 2003-09-23
EA200301129A1 (ru) 2004-04-29
HUP0303795A2 (hu) 2004-03-29
PT1381431E (pt) 2007-07-03
AU2002249041B2 (en) 2007-07-12
EE200300512A (et) 2004-02-16
WO2002083240A1 (en) 2002-10-24
IL158395A0 (en) 2004-05-12
UA79591C2 (en) 2007-07-10
DE60220516T2 (de) 2007-10-11
PL366554A1 (en) 2005-02-07
NZ528501A (en) 2008-04-30
YU81303A (sh) 2006-05-25
BG108316A (bg) 2004-12-30
ZA200307514B (en) 2004-09-27

Similar Documents

Publication Publication Date Title
GB0107669D0 (en) Improvements relating to liver surgery
AU2002359659A8 (en) Cross reference to related application
GB0107495D0 (en) Drawer assist mechanism
GB0103159D0 (en) Public access to the internet
HRP20030838A2 (en) Aromatase inhibition to enhance assisted reproduction
TW573619U (en) Improved structure for magnetic bookmarker
GB0203957D0 (en) Improvements to castors
HUP0402101A3 (en) Butyric acid derivatives
GB0100151D0 (en) Methods of sputtering
AU2001288836A1 (en) Music assisted therapy
AU2003244993A1 (en) Iron
TW493464U (en) Scooter of ice-skate-type
TJ346B (en) Ointment tiomekol
TW496118U (en) Improved structure of dummy fish-bait
GB2370909B (en) Improvements to guitars
AU2002217388A1 (en) Ultrasound assisted lipolysis
PL370598A1 (en) Heterocyclic retinoid compounds
TW554654U (en) Improved structure of water-bailing wheel for water wheel
TW512745U (en) Structure of scooter for running thereon
TW471471U (en) Improved structure for water magnetization
TW506281U (en) Structure of scooter
GB0115727D0 (en) Brake assisted steering
GB2380460B (en) Power-assisted cycles
GB0206602D0 (en) Improvements related to trolleys
GB0208827D0 (en) Faluorination of dicarbonyl compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn